Datavant and Indegene partner to power more efficient clinical trial recruitment

New Delhi: Datavant, the data collaboration platform trusted for healthcare, has announced a strategic partnership with Indegene, a leading digital-first, life sciences commercialization company, to enhance patient recruitment for clinical trials, with a focus on rare disease and other complex studies.

By embedding Datavant’s bespoke data enrichment capabilities into Indegene’s NEXT Patient Recruitment platform, the two companies are enabling faster trial enrollment, fewer screen failures, and more efficient recruitment processes for biopharmaceutical organizations.

Patient recruitment is one of the biggest hurdles in clinical development, particularly in rare diseases where eligible populations are small and dispersed. Datavant operates the nation’s largest health data retrieval network, spanning more than 80,000 hospitals and clinics and processing over 100 million patient records annually. Combined with Indegene’s suite of digitally powered solutions for clinical trial recruitment, the partnership streamlines the identification of suitable participants for studies based on specific health data criteria.

The result is more eligible participants have an opportunity to connect to the trials designed for their specific health conditions, including patients with rare and complex diseases. The partnership enables biopharma companies to reduce site-level screen failures, accelerate enrollment timelines, improve the screen-to-randomization ratios, and drive more informed decision-making.

“Rare diseases have long been defined by the impossibility of finding enough patients fast enough to bring new therapies to market,” said Arnaub Chatterjee, President and GM of Life Sciences of Datavant. “Together with Indegene, we are demonstrating how data enrichment solves that challenge today – and lays the foundation for a new model of clinical research in which sponsors can accelerate recruitment across even the most complex and hard-to-reach populations.”

“We are doubling down on enhancing our capabilities to deliver digital-first recruitment solutions for clients to transform clinical trial execution. Our partnership with Datavant is a key step in this journey,” said Ram Yeleswarapu, SVP, Enterprise Clinical Solutions at Indegene. “By integrating secure, real-time access to consented patient medical records into our screening process, we are minimizing one of the greatest challenges in clinical trials – screen failures at sites due to incomplete and ineffective pre-screening. This collaboration reinforces our positioning as the industry’s premier digital-first recruitment partner, empowering sponsors and sites with data-driven approaches that deliver measurable outcomes.”